FDA panel endorses first-of-a-kind cancer blood test from Grail

Дата публикации: 23-09-2026 23:10:29

Grail Inc.’s Galleri test doesn't diagnose cancer but instead, with a single blood draw, looks for a signal that someone may have one of a long list of tumors.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA panel supports multicancer early detection test	0	9.97	24-09-2026
2	A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy	0	10.91	29-09-2026
3	Laser light enables detection of colorectal cancer biomarker in blood within minutes	0	8.14	25-09-2026
4	ЦТЛ представил на "Биопроме" препарат для диагностики опухолей	0	15.73	05-10-2026
5	New NHS approval creates new hope for patients with rare blood cancers	0	6.31	17-07-2026
6	AI could transform cancer diagnosis across the NHS	0	7.44	11-06-2026
7	Эксперт Каприн: онкомаркеры не могут "проверить" человека сразу на все виды рака	0	7.74	29-09-2026
8	Mapping cancer’s genetic drivers: Sequencing, biomarkers and equity	0	7.44	25-08-2026
9	Want to lower your risk of dementia? It doesn't involve a blood test	0	8.75	15-09-2026
10	First annual breast cancer awareness 5K planned in Dauphin County	0	6.1	26-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.8. Источник: www.ksn.com.